C hronic challenges of the renin-angiotensin system lead to an enhancement of renin gene expression accompanied by hypertrophy of juxtaglomerular cells 1 and by metaplastic transformation of preglomerular vascular smooth muscle cells into renin-producing cells. 2 The cellular mechanisms triggering the recruitment of renin-producing cells are not well understood. It is a common observation in this context that systemic application of nitric oxide synthase (NOS) inhibitors attenuates any stimulation of renin gene expression, regardless of the underlying challenge of the renin system.
C hronic challenges of the renin-angiotensin system lead to an enhancement of renin gene expression accompanied by hypertrophy of juxtaglomerular cells 1 and by metaplastic transformation of preglomerular vascular smooth muscle cells into renin-producing cells. 2 The cellular mechanisms triggering the recruitment of renin-producing cells are not well understood. It is a common observation in this context that systemic application of nitric oxide synthase (NOS) inhibitors attenuates any stimulation of renin gene expression, regardless of the underlying challenge of the renin system. 3 It has been speculated therefore that NO might play a fundamental role for the production of renin. In fact, renin-producing cells and its potential precursor cells are surrounded by cells expressing different NOS isoforms. Thus, endothelial cells express NOS-3, and macula densa cells express NOS-1. 4, 5 A special role of vascular NOS-1 has previously been hypothesized in a state of strong renin cell expression by rennin-angiotensin-aldosterone system (RAAS) inhibition. 6, 7 NO activates NO-sensitive guanylate cyclase (NO-GC) that is present in renin-expressing cells and in preglomerular smooth muscle cells. 8 Cyclic GMP generated by NO-GC can exert a variety of cellular effects, including inhibition of cAMP-phohodiesterase-3 9 that is present in renin-producing cells and in preglomerular smooth muscle cells. 10 Inhibition of phohodiesterase-3 increases intracellular cAMP levels, and thus enhances the cAMP signaling pathway, which is regulatory for renin secretion and fundamental for renin gene transcription, [11] [12] [13] including renin cell recruitment. [14] [15] [16] Although there is agreement about a direct stimulatory effect of NO on renin secretion that is mediated by the cAMP pathway, 17 a direct effect of NO on the metaplastic transformation of vascular smooth muscle cells into renin-producing cells has not yet been established.
It is relevant in this context that systemic inhibition of NOS does not only interfere with NO signaling in renin-producing cells and its potential precursors, but also markedly increases blood pressure. [18] [19] [20] The blood pressure, in particular the renal perfusion pressure, is known as a strong negative regulator of renin cell recruitment. [21] [22] [23] To obtain more information about understanding the mechanisms of renin cell recruitment, our study focused on 2 main goals, namely, first, to identify the origin of NO relevant for renin cell recruitment and, second, to distinguish between indirect (via blood pressure) and direct (via NO-GC) effects of NO on renin cell recruitment.
For this purpose, we used an experimental maneuver, which produced a strong recruitment of renin-producing cells, namely, a combination treatment of low-salt (LS) diet with an angiotensin I-converting enzyme inhibitor. We applied this maneuver to mice with and without systemic NOS inhibition, to mice lacking endothelial NOS (eNOS) and to mice lacking NO-GC in preglomerular smooth muscle cells and renin-expressing cells. Our results suggest that the effects of NO on renin cell recruitment are, in part, directly mediated at the level of the renin-expressing cells and, in part, indirectly mediated by changes of blood pressure.
Methods

Animals
The eNOS -/-mice were generated and provided by Gödecke et al. 24 Wild-type mice (wt) were obtained from the F2 generations of eNOS -/-and C57/Bl6 breedings. Renin cell-specific NO-GC -/-mice were derived from crossings of mice bearing a heterozygous insertion of Cre recombinase in the Ren1d gene locus (Ren1d
Cre/+ ) on a 129SVxC57/Bl6 background 2 and mice carrying a floxed exon 10 of NO-GC-β 1 subunit (NO-GC fl/fl ). 25 Genotyping was performed by PCR on DNA isolated from tail biopsies (NO-GC:
loxP-β 1 -U1 5′-AAGATGCTGAAGGGAAGGATGC-3′; loxP-β 1 -L1 5′-CAGCCCAAAGAAACAAGAAGAAAG-3′; del-β 1 -L1 5′-GATGTGGGATTGTTTCTGAGGA-3′; RenCre:
653 Ren1d 5′-GAAGGAGAGCAAAAGGTAAGAG-3′, 400 Ren1d 5′-GTAGTAGAAGGGGGAGTTGTG-3′; 468 Cre 5′-TTGGTGTACGGTCAGTAAATTGGAC-3′). For studies with Ren1d +/Cre -NO-GC fl/fl animals considered as Ren-GC -/-, Ren1d
+/+ -NO-GC fl/fl were considered as controls. All experiments were performed on male 8-to 12-week-old mice and age-matched controls. Animals were kept on standard rodent chow with free access to tap water. All experiments were conducted according to the National Institutes of Health guidelines for care and use of animals in research. The experiments were approved by the local government.
Treatment Regimen
Ten experimental groups were analyzed. 
Group 2
wt mice on normal chow receiving the NOS-inhibitor, N-nitro-Larginine methyl ester (L-NAME, Sigma Aldrich; 0.5 mg/mL in the tap water), for 3 weeks.
Group 3
wt mice receiving LS diet (0.02% wt/wt NaCl; Ssniff, Germany)+enalapril (Ena, 10 mg/kg×d -1 ; Sigma-Aldrich) for 3 weeks.
Group 4
wt mice receiving LS diet+enalapril and L-NAME for 3 weeks.
Group 5
eNOS -/-mice on normal chow without additional treatment.
Group 6
eNOS -/-mice receiving L-NAME for 3 weeks.
Group 7
eNOS -/-mice receiving LS diet+enalapril for 3 weeks.
Group 8
eNOS -/-mice receiving LS diet+enalapril and L-NAME for 3 weeks.
Group 9
Ren1d
+/Cre -NO-GC fl/fl mice normal chow without additional treatment.
Group 10
Ren1d
+/Cre -NO-GC fl/fl mice receiving LS diet+enalapril for 3 weeks.
Blood Pressure Measurement
Systolic blood pressure of conscious mice was determined by tail cuff manometry (TSE Systems, Germany). After a training period of 7 consecutive days, in which mice were placed into the holding device for 15 minutes per day, the values of 4 days were considered for evaluation.
Immunohistochemistry and 3D Reconstruction
5-µm serial slices of perfusion-fixed paraffin-embedded kidneys were stained for renin and α-smooth muscle actin, as described previously.
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For NO-GC immunostainings, a polyclonal antiguanylyl-cyclase β 1 antibody (ER-19; Sigma Aldrich) was used. After digitalization of 80 to 100 serial slices (Axiovert 200+AxioCam MRm, Zeiss), data for α-smooth muscle actin and renin immunoreactivity were imported into Amira 5.4.2 software (VSG, Germany) for subsequent generation of aligned greyscale-stacks of α-smooth muscle actin and renin. In a labeling step, kidney structures and renin-positive areas were rebuilt from the gray values of each data set.
Volume Calculations
Renin volume per glomerulus was calculated from of 3D kidney reconstructions of 3 animals per experimental group by Amira 5.4.2. as volume pixels (voxels). The number of renin-labeled voxels adjacent to each individual glomerulus and its the respective afferent arteriole up to 30 µm proximal from the vascular pole was taken as a single value.
Isolated Perfused Mouse Kidney
Mouse kidneys were perfused ex situ with a modified KrebsHenseleit solution 27 supplemented with 6 g/100 mL BSA and human red blood cells (10% hematocrit) at a constant pressure of 90 mm Hg, as described previously. 28 After a control perfusion period, sodium nitroprusside (Sigma-Aldrich) at a final concentration of 30 µmol/L was added to the perfusion medium. Every 2 minutes, venous perfusate samples were taken for analysis of renin-secretion rate and perfusate flow was recorded. Renin activity was measured as the generation of angiotensin I in presence of plasma from bilaterally nephrectomized rats, serving as excess of renin substrate. Angiotensin I was determined by radioimmunoassay (RENCTK; DiaSorin, Germany).
Sample Collection
Mice were anesthetized with an intraperitoneal injection of 12 mg/kg xylazine (Serumwerk, Germany) and 80 mg/kg ketamine (Bela-Pharm, Germany). After ligation of the left renal artery, the kidney was excised, frozen in liquid N 2 , and stored for mRNA analysis. For immunohistochemistry and 3D reconstruction, the right kidney was perfusion fixed in situ with a paraformaldehyde solution (3% wt/vol in PBS).
mRNA Analysis
Total RNA was isolated from frozen kidneys and cDNA synthesis, renin and GAPDH mRNA was conducted as described previously.
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Statistical Analysis
Values are denoted as means±SE. Differences between experimental groups were analyzed by ANOVA and Bonferroni adjustment for multiple comparisons. P<0.05 was considered statistically significant.
Results
Renin Cell Distribution in WT Kidneys
In wt mice kept on normal-salt diet, renin-expressing cells were confined to the juxtaglomerular poles of glomeruli ( Figure 1A and 1C). Virtually every juxtaglomerular region contained a few renin-expressing cells that formed an extension of the media layer of afferent arterioles apparatus to the branching of the glomerular capillaries ( Figure 1A and 1C). Feeding wt mice a combination of LS diet together with the angiotensin I-converting enzyme inhibitor enalapril for 3 weeks led to a marked increase of reninexpressing cells ( Figure 1B and 1D ). Additional reninexpressing cells appeared along the media layer of afferent arterioles, and within the periglomerular perivascular cells, which formed cuff-like appositional layers of reninexpressing cells at the glomerular vascular pole, leading to the impression of juxtaglomerular hypertrophy ( Figure  1B and 1D). In parallel, also kidney renin mRNA levels increased 13-fold relative to wt on normal-salt diet ( Figure  2A ). To distinguish between recruitment along afferent arterioles and juxtaglomerular hypertrophy, we calculated renin-immunoreactive volumes per glomerulus from the 3D-reconstructions. Renin immunoreactivity within the first 30 μm from the glomerular vascular pole was considered as juxtaglomerular renin expression (juxtaglomerular hypertrophy). Figure 2B shows that stimulation of renin expression in wt animals led to a 9-fold increase of renin-immunoreactive volume. About two third of this increase occurred in the juxtaglomerular area leading to juxtaglomerular hypertrophy; the remaining one third was a result of vascular recruitment.
Renin Cell Distribution in Kidneys of WT Mice With Systemic NOS Inhibition
Based on our previous finding that systemic inhibition of NO-formation attenuates the increase of renin mRNA in response to LS/Enal, 30 We now examined the effect of the nonselective NOS inhibitor L-NAME on the renin cell recruitment pattern. 3D-reconstruction of renin-expressing cells in combination with the preglomerular vascular tree revealed that recruitment of renin cells along the preglomerular vessels was lacking (Figure 3) . Moreover, juxtaglomerular hypertrophy was attenuated, but not abolished, by treatment with L-NAME (Figures 2B and 3) . This attenuation of renin cell recruitment induced by L-NAME was also reflected by renin mRNA levels, which were markedly lower in animals receiving L-NAME, in addition to the LS/Enal treatment ( Figure  2A) . In wt mice receiving L-NAME on normal salt, renin mRNA levels were moderately reduced by ≈40% (Figure 2A ).
Renin Cell Distribution in Kidneys of Mice Lacking eNOS
Because treatment with L-NAME can also induce side effects that are not specifically related to the availability of NO, 31 we examined in as far the effects of L-NAME on renin cell recruitment can be mimicked by the absence of NOS, in particular, by their endothelial isoform (eNOS). We therefore analyzed renin cell recruitment in mice lacking endothelial NOS (eNOS -/-). In eNOS -/-mice, renin cells were located at typical juxtaglomerular position ( Figure 4A and 4C ), but basal renin mRNA expression was reduced by 50% (Figure 2A ). LS diet in combination with enalapril induced no recruitment of renin cells along afferent arterioles in eNOS -/-mice ( Figure  4B and 4D) . Juxtaglomerular hypertrophy developed, but to a clearly lesser extent, as in wt mice ( Figures 2B, 4B, and 4D ). In line, the increase of renin mRNA was markedly attenuated in eNOS -/-mice ( Figure 2 ). To address a possible additional role of also other NOS, such as inducible or neuronal NOS, for renin cell recruitment, we analyzed renin cell expression in eNOS -/-mice that were treated with the nonselective NOS inhibitor L-NAME on top. L-NAME treatment of eNOS -/-mice, however, did not produce an additional effect on renin mRNA levels ( Figure 2A ) nor on renin cell recruitment ( Figure S1 in the online-only Data Supplement), neither under basal conditions nor during stimulation with LS diet in combination with enalapril.
Renin Cell Distribution in Kidneys of Mice Lacking Soluble Guanylate Cyclase in Renin-Producing Cells
Assuming a relevant role of endothelium-derived NO for renin cell recruitment led to the question about signaling pathways along which NO could exert its effect on renin expression. A well-documented pathway of NO action is the activation of NO-GC in its target cells. 32 Within the kidney, NO-GC expression as indicated by NO-GC-β 1 immunoreactivity was found in mesangial cells, renin-producing cells, vascular smooth muscle cells, and interstitial cells ( Figure 5A ). We therefore aimed to study renin cell recruitment in mice lacking NO-GC in renin-expressing cells and in renin cell precursors. For this purpose, we generated mice lacking NO-GC in renin-expressing cells, and their descendents with the Cre-lox recombination system (Ren1d In Ren1d +/Cre -NO-GC fl/fl kidneys, renin cells were located at typical juxtaglomerular position, but basal renin expression was slightly reduced by 20% (Figure 2) . LS diet in combination with enalapril induced no recruitment of renin cells along afferent arterioles in Ren1d +/Cre -NO-GC fl/fl mice ( Figure 7 ). Juxtaglomerular hypertrophy, however, was developed to a very similar extent as in wt mice ( Figures 2B and 7) . In accordance, renin mRNA levels were reduced by 30% in comparison with wt mice (Figure 2 ).
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Blood Pressure
Because the blood pressure is considered as an important factor influencing renin cell recruitment, 21 ,33,34 we measured systolic blood pressure values of animals enrolled in this study (Table) . It turned out that wt mice treated with L-NAME and eNOS -/-mice were clearly hypertensive with average systolic blood pressure values around 160 mm Hg (versus 125 mm Hg in untreated wt mice). L-NAME treatment of eNOS -/-mice did not further increase blood pressure. Ren1d
+/Cre -NO-GC fl/fl mice had normal blood pressure. LS diet in combination with enalapril treatment for 3 weeks lowered blood pressure to around 85 to 90 mm Hg in wt and in Ren1d +/Cre -NO-GC fl/fl mice, and to around 115 to 120 mm Hg in wt mice treated with L-NAME and in eNOS -/-mice. L-NAME treatment of eNOS -/-mice exerted no effect on blood pressure.
Discussion
This study aimed to define the role of NO for the hypertrophy of the juxtaglomerular apparatus and for recruitment of reninexpressing cells along the muscular media layer of afferent arterioles in the kidney, in situations of a chronically challenged renin-angiotensin-aldosterone system.
Our results show, and thus confirm previous reports, 3, 30 that inhibition of NO-formation attenuates the compensatory increase in renin expression induced by blockade of the RAAS, suggesting that the availability of NO is relevant for this process. Going beyond that, our data now demonstrate that the availability of NO is required for the recruitment of additional renin-producing cells, in particular, for the metaplastic transformation of preglomerular vascular smooth muscle cells into renin-producing cells, and to a lesser extent, also for transformation of juxtaglomerular cells into renin producers. Our data also strongly suggest that it is eNOS-derived NO that is relevant in this context, because the effects of systemic NOS blockade and of eNOS deletion on renin cell recruitment GC; A,B), renin (C,D) , and α-smooth muscle actin (α-SMA; E,F). Arrows indicate colocalization of GC-renin-α-SMA. Arrowheads indicate absence of colocalization. could not be distinguished on the level of renin cell distribution, nor on the level of renin mRNA. Moreover, systemic NOS-blockade exerted no additional effect on renin cell recruitment in the absence of eNOS. Therefore, we conclude that it is eNOS-derived rather than NO from other sources that is relevant for renin cell recruitment. Although extraendothelial localizations of eNOS have meanwhile been identified, the endothelium is considered as the main expression site of eNOS. 4, 35 Assuming that it is NO of endothelial origin that is important for renin cell recruitment, both indirect and direct effects of NO on renin-producing cells and their precursors might explain the effects of NO. The indirect effect of endothelial NO on renin cell recruitment would be related to the relevance of endothelial NO for systemic vascular resistance and blood pressure. It is well known that inhibition of endothelial NO formation induces hypertension, 24, [36] [37] [38] [39] as also seen in this study. Hypertension per se would be expected to lower renin expression and to reduce the number of renin-producing cells in the kidney. In a previous rat study, we have found that inhibition of NO synthesis with L-NAME increases blood pressure and counteracts the stimulation of renin expression by RAAS-blockade. In that study, we also found that there was no clear correlation of blood pressure increase and inhibition of renin expression on the level of individual animals, 40 suggesting that mechanisms other than blood pressure changes might also contribute to the effect of NO on renin cell recruitment. One obvious mechanism in this context would be a direct effect of NO on renin cells and their precursors.
The most common signaling pathway of endothelial NO in blood vessels is the activation of NO-GC. 32, 41 In confirmation of a previous report, we found NO-GC protein in reninproducing, mesangial and vascular smooth muscle cells. 8 Our data now show that in mice lacking NO-GC in renin-producing and vascular smooth muscle cells, recruitment of renin cells in afferent arterioles is absent like in eNOS-deficient mice, whereas blood pressure is not different from wt mice. These findings suggest that the intravascular eNOS-NO-NO-GC pathway is important for the metaplastic transformation of vascular smooth muscle cells into renin-producing cells.
Although it cannot be definitively ruled out that the influence of intrarenal NO-GC on renin cell recruitment could be indirectly mediated by its effect on renal vascular resistance and, in consequence, on renal perfusion, we consider this possibility less likely for 2 main reasons. First, in situations in which intrarenal perfusion pressure and perfusion rate change, pressure but not perfusion determines the function of renin-producing cells. 23 At constant perfusion pressure, there is no obvious link between perfusion rate and the function of renin-producing cells. 42, 43 Second, there would exist a plausible explanation for a direct role of NO-NO-GC for renin cell recruitment. We and others have previously obtained pharmacological and functional evidence that the NO-NO-GC pathway stimulates renin secretion and decreases renovascular resistance through the cAMP signaling pathway by inhibition of phosphodiesterase-3. 9, 10, 44 Activation of the cAMP signaling pathway is, in fact, also considered to be essential for the transformation of vascular smooth muscles cells into reninproducing cells, [14] [15] [16] thus providing an explanation for the role of NO-GC in renin cell recruitment. Whether the role of NO-NO-GC in renin cell recruitment is a direct regulatory one, by upregulating and downregulating cAMP levels, or more a sensitizing one, by stabilizing cAMP levels thus supporting the activity of regulatory adenylate cyclase activators, cannot be directly answered from this study. Available evidence, however, suggests that renin and renal eNOS expression are inversely regulated by the RAAS activity. Thus, infusion of angiotensin II that suppresses renin expression upregulates eNOS expression, 45 whereas animals lacking angiotensinogen, which have elevated renin expression, show reduced eNOS expression. 46 Therefore, we speculate that the role of NO-GC in renin cell recruitment is a sensitizing rather than a regulatory one.
It is, of note, that juxtaglomerular hypertrophy was not altered in the absence of NO-GC, whereas it was attenuated in eNOS-deficient mice. If it is the activation of the cAMP signaling pathway that causes transformation of juxtaglomerular precursors into renin-producing cells, then it does not require stabilization of cAMP levels by NO-GC cGMP-induced phohodiesterase-3 inhibition. This could indicate that there is already strong activation of adenylate cyclase in these cells. A likely adenylate cyclase activator candidate in this context could be prostaglandin E 2 that is produced by the macula densa cells, regulated by their cyclooxygenase-2 activity. [47] [48] [49] LS diet in combination with angiotensin I-converting enzyme inhibitor treatment causes an almost 10-fold increase of COX-2 expression in the macula densa, suggesting strong juxtaglomerular prostanoid formation in this situation. 50 In line, stimulation of renin expression by RAAS inhibition is attenuated in COX-2-deficient mice 51, 52 and in wt mice treated with selective COX-2 inhibitors. 53 Such a role of macula densaderived prostanoids for juxtaglomerular renin cell recruitment induced by RAAS inhibition could also explain the attenuated juxtaglomerular hypertrophy seen in eNOS-deficient mice, because the stimulation of COX-2 expression by RAAS inhibition is clearly attenuated in states of hypertension.
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Perspectives
The recruitment of renin-expressing cells in response to chronic challenges of the renin-angiotensin system comprises 2 distinct components, namely metaplastic transformation of smooth muscle cells of preglomerular vessels and induction of renin expression in perivascular cells in the juxtaglomerular area. Metaplastic transformation of vascular smooth muscle appears to be dependent on the local availability of endothelium-derived NO and cGMP levels in renin precursor cells. Recruitment of renin-expressing cells in the juxtaglomerular area is likely dependent on the renal perfusion pressure in a more NO-independent manner. As endothelial production of NO can be compromised in states of disease, such a deficit of NO may become relevant for the correct adaptation of the renin-angiotensin system to demand.
